A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial

R J Prescott, I H Kunkler, L J Williams, C C King, W Jack, M van der Pol, T T Goh, R Lindley, J Cairns

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

To assess whether omission of postoperative radiotherapy in women with 'low-risk' axillary node negative breast cancer (T0-2) treated by breast-conserving surgery and endocrine therapy improves quality of life and is more cost-effective.
Original languageEnglish
Pages (from-to)1-149, iii-iv
JournalHealth Technology Assessment
Volume11
Issue number31
DOIs
Publication statusPublished - Aug 2007

Keywords / Materials (for Non-textual outputs)

  • Aged
  • Breast Neoplasms
  • Cancer Care Facilities
  • Fatigue
  • Female
  • Great Britain
  • Hormone Replacement Therapy
  • Humans
  • Mastectomy, Segmental
  • Nursing Assessment
  • Postoperative Care
  • Quality of Life
  • Quality-Adjusted Life Years
  • Questionnaires
  • Radiotherapy, Adjuvant
  • Risk Assessment
  • Sleep Initiation and Maintenance Disorders
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial'. Together they form a unique fingerprint.

Cite this